COGT

SEC source: 0000899243-23-014905 · doc4.xml · derivative · entry 1

Morris Arlene · CIK 0001362520 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,700

Underlying: Common Stock · 36,700 shares

Expires 2033-06-07

F1 · derivative.exercise_date: This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders.

SEC source: 0000899243-23-014900 · doc4.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,700

Underlying: Common Stock · 36,700 shares

Expires 2033-06-07

F1 · derivative.exercise_date: This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders.

SEC source: 0000899243-23-014883 · doc4.xml · derivative · entry 1

Harwin Peter Evan · CIK 0001663607 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,700

Underlying: Common Stock · 36,700 shares

Expires 2033-06-07

F1 · derivative.exercise_date: This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders.

F2 · ownership.direct: Under the Reporting Person's arrangement with Fairmount Funds Management LLC (the "Adviser"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a "Fairmount Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.

SEC source: 0000899243-23-014895 · doc4.xml · derivative · entry 1

Shegog Todd · CIK 0001714564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,700

Underlying: Common Stock · 36,700 shares

Expires 2033-06-07

F1 · derivative.exercise_date: This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders.

SEC source: 0000899243-23-010391 · doc4.xml · derivative · entry 1

Ros Matthew · CIK 0001673802 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,900

Underlying: Common Stock · 1,900 shares

Expires 2033-04-03

F1 · price: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0000899243-23-010395 · doc4.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,053

Underlying: Common Stock · 2,053 shares

Expires 2033-04-03

F1 · price: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0000899243-23-005140 · doc4.xml · derivative · entry 1

Kearns Evan · CIK 0001745285 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Stock · 140,000 shares

Expires 2033-02-13

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a four year period.

SEC source: 0000899243-23-005135 · doc4.xml · derivative · entry 1

Robbins Andrew R · CIK 0001590157 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 525,000

Underlying: Common Stock · 525,000 shares

Expires 2033-02-13

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a four year period.

SEC source: 0000899243-23-005141 · doc4.xml · derivative · entry 1

Robinson John Edward · CIK 0001856514 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2033-02-13

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a four year period.

SEC source: 0000899243-23-005137 · doc4.xml · derivative · entry 1

Green John L. · CIK 0001709773 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-02-13

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a four year period.

SEC source: 0000899243-23-005138 · doc4.xml · derivative · entry 1

Sachs Jessica · CIK 0001782545 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2033-02-13

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a four year period.

SEC source: 0000899243-23-000619 · doc4.xml · derivative · entry 1

Ros Matthew · CIK 0001673802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,792

Underlying: Common Stock · 1,792 shares

Expires 2033-01-03

F1 · price: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0000899243-23-000615 · doc4.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,862

Underlying: Common Stock · 1,862 shares

Expires 2033-01-03

F1 · price: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0000899243-22-032672 · doc4.xml · derivative · entry 1

Ros Matthew · CIK 0001673802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,419

Underlying: Common Stock · 1,419 shares

Expires 2032-10-03

F1 · price: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0000899243-22-032661 · doc4.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,474

Underlying: Common Stock · 1,474 shares

Expires 2032-10-03

F1 · price: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0000899243-22-024929 · doc4.xml · derivative · entry 1

Ros Matthew · CIK 0001673802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,194

Underlying: Common Stock · 2,194 shares

Expires 2032-07-01

F1 · price: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0000899243-22-024930 · doc4.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,279

Underlying: Common Stock · 2,279 shares

Expires 2032-07-01

F1 · price: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0000899243-22-024711 · doc4.xml · nonDerivative · entry 1

Sachs Jessica · CIK 0001782545 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 622

F1 · shares: The shares were acquired under the Cogent Biosciences, Inc. 2018 Employee Stock Purchase Plan. The transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).

SEC source: 0001104659-22-072798 · tm2218841-1_4seq1.xml · nonDerivative · entry 2

Fairmount Funds Management LLC · CIK 0001802528 · 10% owner · See Remarks

10b5-1 filing: Not disclosed

Ownership: Indirect · Fairmount Healthcare Fund II LP

Disclosed balance after: 2,472,124

F2 · ownership.nature: Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the shares of Common Stock and Series A Preferred Stock held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.

SEC source: 0000899243-22-021643 · doc4.xml · derivative · entry 1

CAIN CHRISTOPHER W. · CIK 0001817733 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,700

Underlying: Common Stock · 30,700 shares

Expires 2032-06-07

F1 · derivative.exercise_date: This annual stock option award was made on the date of the 2022 Annual Meeting of Stockholders pursuant to the company's Non-Employee Director Compensation Program and shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2023 Annual Meeting of Stockholders.

SEC source: 0000899243-22-021645 · doc4.xml · derivative · entry 1

Ros Matthew · CIK 0001673802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,700

Underlying: Common Stock · 30,700 shares

Expires 2032-06-07

F1 · derivative.exercise_date: This annual stock option award was made on the date of the 2022 Annual Meeting of Stockholders pursuant to the company's Non-Employee Director Compensation Program and shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2023 Annual Meeting of Stockholders.

SEC source: 0000899243-22-021646 · doc4.xml · derivative · entry 1

Morris Arlene · CIK 0001362520 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,700

Underlying: Common Stock · 30,700 shares

Expires 2032-06-07

F1 · derivative.exercise_date: This annual stock option award was made on the date of the 2022 Annual Meeting of Stockholders pursuant to the company's Non-Employee Director Compensation Program and shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2023 Annual Meeting of Stockholders.

SEC source: 0000899243-22-021648 · doc4.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,700

Underlying: Common Stock · 30,700 shares

Expires 2032-06-07

F1 · derivative.exercise_date: This annual stock option award was made on the date of the 2022 Annual Meeting of Stockholders pursuant to the company's Non-Employee Director Compensation Program and shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2023 Annual Meeting of Stockholders.

SEC source: 0000899243-22-021639 · doc4.xml · derivative · entry 1

Harwin Peter Evan · CIK 0001663607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,700

Underlying: Common Stock · 30,700 shares

Expires 2032-06-07

F1 · derivative.exercise_date: This annual stock option award was made on the date of the 2022 Annual Meeting of Stockholders pursuant to the company's Non-Employee Director Compensation Program and shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2023 Annual Meeting of Stockholders.

SEC source: 0000899243-22-021636 · doc4.xml · derivative · entry 1

Shegog Todd · CIK 0001714564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,700

Underlying: Common Stock · 30,700 shares

Expires 2032-06-07

F1 · derivative.exercise_date: This annual stock option award was made on the date of the 2022 Annual Meeting of Stockholders pursuant to the company's Non-Employee Director Compensation Program and shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2023 Annual Meeting of Stockholders.

SEC source: 0000899243-22-013702 · doc4.xml · derivative · entry 1

Ros Matthew · CIK 0001673802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,650

Underlying: Common Stock · 2,650 shares

Expires 2032-04-01

F1 · price: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0000899243-22-013710 · doc4.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,753

Underlying: Common Stock · 2,753 shares

Expires 2032-04-01

F1 · price: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0000899243-22-003469 · doc4.xml · derivative · entry 1

Kearns Evan · CIK 0001745285 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,250

Underlying: Common Stock · 202,250 shares

Expires 2032-01-25

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a four year period.

SEC source: 0000899243-22-003462 · doc4.xml · derivative · entry 1

Robbins Andrew R · CIK 0001590157 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 690,000

Underlying: Common Stock · 690,000 shares

Expires 2032-01-25

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a four year period.

SEC source: 0000899243-22-003475 · doc4.xml · derivative · entry 1

Green John L. · CIK 0001709773 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2032-01-25

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a four year period.

SEC source: 0000899243-22-003474 · doc4.xml · derivative · entry 1

Sachs Jessica · CIK 0001782545 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2032-01-25

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a four year period.

SEC source: 0000899243-22-003465 · doc4.xml · derivative · entry 1

Robinson John Edward · CIK 0001856514 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2032-01-25

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a four year period.

SEC source: 0000899243-22-000691 · doc4.xml · derivative · entry 1

Ros Matthew · CIK 0001673802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,256

Underlying: Common Stock · 2,256 shares

Expires 2032-01-03

F1 · shares: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

F2 · derivative.exercise_date: This option is fully vested at time of grant.

SEC source: 0000899243-22-000693 · doc4.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,329

Underlying: Common Stock · 2,329 shares

Expires 2032-01-03

F1 · shares: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

F2 · derivative.exercise_date: This option is fully vested at time of grant.

SEC source: 0000899243-22-000694 · doc4.xml · nonDerivative · entry 1

Sachs Jessica · CIK 0001782545 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 674

F1 · shares: The shares were acquired under the Cogent Biosciences, Inc. 2018 Employee Stock Purchase Plan. The transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).

SEC source: 0000899243-21-039303 · doc4.xml · derivative · entry 1

Ros Matthew · CIK 0001673802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,463

Underlying: Common Stock · 2,463 shares

Expires 2031-10-01

F1 · shares: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

F2 · derivative.exercise_date: This option is fully vested at time of grant.

SEC source: 0000899243-21-039329 · doc4.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,385

Underlying: Common Stock · 2,385 shares

Expires 2031-10-01

F1 · shares: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

F2 · derivative.exercise_date: This option is fully vested at time of grant.

SEC source: 0000899243-21-027628 · doc4.xml · derivative · entry 1

Ros Matthew · CIK 0001673802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,225

Underlying: Common Stock · 2,225 shares

Expires 2031-07-01

F1 · shares: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

F2 · derivative.exercise_date: This option is fully vested at time of grant.

SEC source: 0000899243-21-027625 · doc4.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,513

Underlying: Common Stock · 2,513 shares

Expires 2031-07-01

F1 · shares: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

F2 · derivative.exercise_date: This option is fully vested at time of grant.

SEC source: 0000899243-21-018362 · doc4.xml · derivative · entry 1

Kearns Evan · CIK 0001745285 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,000

Underlying: Common Stock · 260,000 shares

Expires 2031-05-03

F1 · derivative.exercise_date: This stock option shall vest over a four year period as follows: 1/4th of the option shall vest one year after the vesting start date; then 1/48th of the option shall vest monthly over the remaining three year period.

SEC source: 0000899243-21-017261 · doc4.xml · nonDerivative · entry 1

Green John L. · CIK 0001709773 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,841

F1 · security: The shares were sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units previously granted to the Reporting Person.

F2 · price: The price reported in Column 4 was the weighted-average sale price of the shares. The shares were sold in multiple transactions at prices ranging from $8.80 to $8.90. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range set forth herein.

SEC source: 0000899243-21-014967 · doc4.xml · derivative · entry 1

Ros Matthew · CIK 0001673802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,068

Underlying: Common Stock · 2,068 shares

Expires 2031-04-01

F1 · shares: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

F2 · derivative.exercise_date: This option is fully vested at time of grant.

SEC source: 0000899243-21-014969 · doc4.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,121

Underlying: Common Stock · 2,121 shares

Expires 2031-04-01

F1 · shares: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

F2 · derivative.exercise_date: This option is fully vested at time of grant.

SEC source: 0000899243-21-011693 · doc4.xml · derivative · entry 1

CAIN CHRISTOPHER W. · CIK 0001817733 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2031-03-11

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a three year period.

SEC source: 0000899243-21-011694 · doc4.xml · derivative · entry 1

Ros Matthew · CIK 0001673802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2031-03-11

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a three year period.

SEC source: 0000899243-21-011688 · doc4.xml · derivative · entry 1

Morris Arlene · CIK 0001362520 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2031-03-11

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a three year period.

SEC source: 0000899243-21-011698 · doc4.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2031-03-11

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a three year period.

SEC source: 0000899243-21-011730 · doc4.xml · derivative · entry 1

Harwin Peter Evan · CIK 0001663607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2031-03-11

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a three year period.

SEC source: 0000899243-21-011695 · doc4.xml · derivative · entry 1

Shegog Todd · CIK 0001714564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2031-03-11

F1 · derivative.exercise_date: This stock option shall vest in equal monthly installments over a three year period.

SEC source: 0000899243-21-008812 · doc4.xml · nonDerivative · entry 1

Green John L. · CIK 0001709773 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,654

F1 · security: Reflects shares of common stock issued to the Reporting Person in accordance with the terms of the Contingent Value Rights distributed to certain stockholders pursuant to the Contingent Value Rights Agreement on July 6, 2020.